Reacciones adversas medicamentosas graves: síndrome de Stevens-Johnson y necrólisis epidérmica tóxica

Crosi, Alejandro; Borges González, Silvana; Estévez Carrizo, Francisco E.
Rev. méd. Urug ; 20: 172-7, dic. 2004.
Artículo en Español | BVSNACUY | ID: bnu-12926

Documentos relacionados

  1. Stevens-Johnson syndrome in children.
  2. High risk and low prevalence diseases: Stevens Johnson syndrome and toxic epidermal necrolysis.
  3. Stevens-Johnson syndrome and toxic epidermal necrolysis from pathologist's point of view.
  4. Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus.
  5. Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Call for Optimum Patient Stratification and Theranostics via Pharmacogenomics.
  6. Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN).
  7. Enfortumab Vedotin-Associated Toxic Epidermal Necrolysis-like Toxic Erythema of Chemotherapy.
  8. Toxic epidermal necrolysis-like presentation of toxic erythema of chemotherapy.
  9. Fast, bedside diagnosis of toxic epidermal necrolysis using ex vivo confocal laser scanning microscopy: A retrospective study.
  10. Severe reactive infectious mucocutaneous eruption mimicking drug-induced epidermal necrolysis triggered by norovirus.